Back
 
Pharmacogenomics: Applying the Science to Community Pharmacy
On June 26, 2000, President Bill Clinton and British Prime Minister Tony Blair jointly announced that a rough draft of the human genome sequence had been completed as part of the Human Genome Project. This project, officially completed three years later, was expected to fundamentally change the way medicine is practiced. As we pass 15 years from the official completion of the Human Genome Project, there are numerous examples of realized dreams in the field of genomics and countless areas where more work needs to be completed.
Pharmacogenomics: Applying the Science to Community Pharmacy

Pharmacogenomics: Applying the Science to Community Pharmacy
Please read through the following information and click Continue.

ACPE Universal Program Number: 0207-0000-18-008-H04-P; 0207-0000-18-008-H04-T
Release Date: August 1, 2018
Expiration Date: August 1, 2021
Activity Type: Application-based

Statement of Need
On June 26, 2000, President Bill Clinton and British Prime Minister Tony Blair jointly announced that a rough draft of the human genome sequence had been completed as part of the Human Genome Project. This project, officially completed three years later, was expected to fundamentally change the way medicine is practiced. As we pass 15 years from the official completion of the Human Genome Project, there are numerous examples of realized dreams in the field of genomics and countless areas where more work needs to be completed.

Pharmacist Learning Objectives
Upon successful completion of this activity, the pharmacist should be better able to:

  1. Summarize legal considerations for pharmacists considering pharmacogenomic services.
  2. Use pharmacogenomic resources to identify appropriate treatment recommendations for patients.
  3. Explain how pharmacogenomic tests are completed and results are shared with patients.

Pharmacy Technician Learning Objectives
Upon successful completion of this activity, the pharmacy technician should be better able to:

  1. Summarize legal considerations for pharmacies considering pharmacogenomic services.
  2. Use pharmacogenomic resources to assist pharmacists with identifying appropriate treatment recommendations for patients.
  3. Explain how pharmacogenomic tests are completed and results are shared with patients.

Any medications or treatment methods suggested in this activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication. This article contains a discussion of off-label uses that will be identified as such by the author.

Target Audience
The target audience for this activity is Pharmacists and Pharmacy Technicians.

Instructions for Participation
To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:

  • Review the content of the activity.
  • Successfully complete the post-test (70% or higher).
  • You will have two (2) opportunities to successfully complete the activity.

Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.

Fee
There is no fee for this activity.

Accreditation
Pharmacists & Pharmacy Technicians
ACPE logoNCPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity will provide 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit under the numbers 0207-0000-18-008-H04-P and 0207-0000-18-008-H04-T.

Faculty
Kevin Day, PharmD, is clinical director at Day's Miami Heights Pharmacy in Cincinnati.

Disclosure Declaration
It is the policy of the National Community Pharmacists Association (NCPA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.

The authors, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.

Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.

Software Requirements

PC
Internet Explorer (Latest Version)
 or Firefox (Latest Version)
*Adobe Acrobat Reader

MAC
Safari (Latest Version)
Firefox (Latest Version)
*Adobe Acrobat Reader

*REQUIRED TO VIEW PRINTABLE VERSION OF CE LESSON

 


Type:     Application-based CPE Activity
239 Registered Users